Goldman Sachs’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
Goldman Sachs's ACHC Position: Q1 2026 in Review
Goldman Sachs reduced its Acadia Healthcare (ACHC) stake by 53% in Q1 2026, selling an estimated $45M and leaving 2,240,428 shares worth $52.4M. The position accounts for 0.01% of the portfolio, ranked #1540.
Goldman Sachs first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $216M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- Goldman Sachs held 2,240,428 shares of Acadia Healthcare worth $52.4M as of Q1 2026.
- Goldman Sachs sold 2,488,185 Acadia Healthcare shares in Q1 2026, an estimated $45M.
- Acadia Healthcare made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1540 holding.
- Goldman Sachs first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Acadia Healthcare position peaked at $216M in Q2 2017.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.